Loss of Exclusivity – Bespoke Report

Nov 20, 2020 | General

Wavedata are frequently asked to perform bespoke analyses of our pricing data. This reflects the prices paid for medical supplies by pharmacies and dispensing doctors, with data going as far back to the year 2000. One example of the type of reports we can run is ‘loss of exclusivity’, showing the price decline of generic products after the originator lost its patent protection and generics were launched. They are usually used by branded companies to get a feel for how long a commercial department would be able to keep the brand alive with equalisation deals.

An example of one of these reports is below: Zonisamide Caps Price in £ from Nov 2015 to Aug 2020. This graph contains details of three pack sizes.

Need to identify a product opportunity? Contact us for a bespoke report at

Share This